Nagatsu T, Ichinose H
Institute for Comprehensive Medical Science, Fujita Health University Toyoake, Aichi, Japan.
Vopr Med Khim. 1998 May-Jun;44(3):225-8.
The development of autosomal dominant DOPA-responsive dystonia (AD-DRD) is stipulated by mutation in GTP-cyclohydrolase I gene. GTP-cyclohydrolase I is the first and key enzyme of tetrahydrobiopterin biosynthesis. Its deficiency in nigrostriatal dopaminergic neurons cause a decrease in tyrosine hydroxylase activity and therefore dopamine deficiency. However, administration of low doses of dopamine can control the development of AD-DRD. Determination of GTP-cyclohydrolase I activity in mononuclear blood cells is convenient diagnostic method.
常染色体显性遗传性多巴反应性肌张力障碍(AD-DRD)的发生由GTP-环化水解酶I基因突变所决定。GTP-环化水解酶I是四氢生物蝶呤生物合成的首个关键酶。其在黑质纹状体多巴胺能神经元中的缺乏导致酪氨酸羟化酶活性降低,进而造成多巴胺缺乏。然而,低剂量多巴胺给药可控制AD-DRD的发展。测定单核血细胞中的GTP-环化水解酶I活性是一种简便的诊断方法。